Anti-GD2 antibody for radiopharmaceutical imaging of osteosarcoma.
Yingli FuJing YuIoanna LiatsouYong DuAnders JosefssonJessie R NedrowHans RindtJeffrey N BryanDara L KraitchmanRobert F HobbsPublished in: European journal of nuclear medicine and molecular imaging (2022)
This study demonstrates the feasibility of targeting GD2 on OS cells and spontaneous OS canine tumors using hu3F8-based radiopharmaceutical imaging. Its ability to deliver an imaging payload in a targeted manner supports the utility of hu3F8 for precision imaging of OS and potential future use in radiopharmaceutical therapy.